Current Treatment of Cooley's Anemia
- 17 December 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 612 (1) , 286-292
- https://doi.org/10.1111/j.1749-6632.1990.tb24316.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJORPublished by Elsevier ,1989
- Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia MajorNew England Journal of Medicine, 1985
- Current Therapy and New Approaches to the Treatment of Thalassemia MajorAnnals of the New York Academy of Sciences, 1985
- The Effect of Subcutaneous Deferoxamine on the Cardiac Profile of Thalassemia Major: A Five‐Year StudyAnnals of the New York Academy of Sciences, 1985
- Treatment of Iron Overload in Cooley's AnemiaaAnnals of the New York Academy of Sciences, 1985
- Depletion of excessive liver iron stores with desferrioxamineBritish Journal of Haematology, 1984
- DECREASING IRON STORES DURING INTENSIVE CHELATION THERAPY *Annals of the New York Academy of Sciences, 1980
- CURRENT CONCEPTS IN THE OVERALL MANAGEMENT OF THALASSEMIAAnnals of the New York Academy of Sciences, 1980
- Iron chelation therapy with deferoxamine in Cooley anemiaThe Journal of Pediatrics, 1978
- LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIAAnnals of the New York Academy of Sciences, 1974